HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi Hu Selected Research

tyrosyl-glutamyl-tyrosyl-glutamic acid (TGTG)

9/2015An association study of NRAMP1, VDR, MBL and their interaction with the susceptibility to tuberculosis in a Chinese population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi Hu Research Topics

Disease

171Neoplasms (Cancer)
10/2022 - 01/2003
49Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 03/2006
28Neoplasm Metastasis (Metastasis)
01/2022 - 08/2006
25Infections
01/2022 - 10/2009
22Esophageal Squamous Cell Carcinoma
08/2021 - 01/2009
21Adenocarcinoma of Lung
01/2022 - 11/2007
20Carcinoma (Carcinomatosis)
01/2022 - 01/2003
19Lung Neoplasms (Lung Cancer)
07/2022 - 07/2007
18Glioma (Gliomas)
11/2021 - 12/2007
17Tuberculosis (Tuberculoses)
01/2022 - 11/2009
16Esophageal Neoplasms (Esophageal Cancer)
01/2022 - 11/2005
14Breast Neoplasms (Breast Cancer)
01/2022 - 01/2002
13Inflammation (Inflammations)
11/2022 - 10/2016
12Pneumonia (Pneumonitis)
03/2022 - 01/2017
12COVID-19
01/2021 - 01/2020
10Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 10/2008
10Carcinogenesis
12/2021 - 10/2016
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 11/2004
8Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2022 - 06/2008
8Disease Progression
01/2022 - 09/2011
8Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2021 - 11/2015
8Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2014
8Hemorrhagic Shock
01/2020 - 01/2011
7Melanoma (Melanoma, Malignant)
01/2022 - 01/2014
7Adenocarcinoma
01/2021 - 08/2010
7Shock
07/2019 - 02/2011
6Hemorrhage
02/2021 - 01/2013
6Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 11/2014
6Lymphatic Metastasis
01/2019 - 02/2010
6Pathologic Constriction (Stenosis)
01/2017 - 01/2003
5Hypoxia (Hypoxemia)
01/2022 - 01/2008
5Parkinson Disease (Parkinson's Disease)
11/2021 - 04/2010
5Glioblastoma (Glioblastoma Multiforme)
01/2021 - 01/2015
5Brain Neoplasms (Brain Tumor)
01/2020 - 12/2007
4Sepsis (Septicemia)
01/2022 - 10/2020
4Reinfection
12/2021 - 01/2017
4Triple Negative Breast Neoplasms
10/2021 - 01/2019
4Asthma (Bronchial Asthma)
08/2021 - 10/2015
4Periodontitis
03/2021 - 01/2018
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2018
4Schistosomiasis (Bilharziasis)
01/2021 - 01/2014
4Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 10/2011
4Alzheimer Disease (Alzheimer's Disease)
12/2019 - 04/2012
4Bacterial Infections (Bacterial Infection)
01/2019 - 05/2011

Drug/Important Bio-Agent (IBA)

46Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2002
44Pharmaceutical PreparationsIBA
07/2022 - 01/2002
31Biomarkers (Surrogate Marker)IBA
11/2022 - 09/2011
28Immune Checkpoint InhibitorsIBA
03/2022 - 01/2017
19MicroRNAs (MicroRNA)IBA
01/2021 - 06/2011
17Messenger RNA (mRNA)IBA
06/2021 - 06/2005
16Biological ProductsIBA
06/2021 - 07/2009
11Long Noncoding RNAIBA
06/2022 - 08/2015
11Cisplatin (Platino)FDA LinkGeneric
10/2021 - 03/2006
9CateninsIBA
11/2021 - 11/2010
9CytokinesIBA
05/2021 - 10/2009
8Doxorubicin (Adriamycin)FDA LinkGeneric
07/2022 - 01/2002
8ErbB Receptors (EGF Receptor)IBA
01/2022 - 09/2011
8Indicators and Reagents (Reagents)IBA
01/2022 - 11/2007
8Reactive Oxygen Species (Oxygen Radicals)IBA
11/2020 - 01/2016
8AntigensIBA
10/2020 - 12/2005
7Oxygen (Dioxygen)IBA
01/2022 - 02/2014
7VaccinesIBA
11/2021 - 01/2019
7Peptides (Polypeptides)IBA
01/2021 - 03/2014
7PlatinumIBA
12/2020 - 10/2006
7Therapeutic UsesIBA
06/2019 - 12/2007
6LipidsIBA
07/2022 - 01/2021
6Bevacizumab (Avastin)FDA Link
01/2022 - 01/2014
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 08/2010
6Small Interfering RNA (siRNA)IBA
10/2021 - 01/2013
6AntibodiesIBA
01/2020 - 05/2009
5RNA (Ribonucleic Acid)IBA
01/2022 - 01/2017
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 03/2009
5Pemetrexed (MTA)FDA Link
01/2021 - 05/2010
5Immunoglobulin G (IgG)IBA
01/2021 - 12/2010
5Monoclonal AntibodiesIBA
12/2020 - 02/2012
5ParaffinIBA
01/2019 - 01/2009
4Chimeric Antigen ReceptorsIBA
03/2022 - 01/2015
4Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022 - 01/2020
4Glutathione (Reduced Glutathione)IBA
12/2021 - 01/2016
4130-nm albumin-bound paclitaxelIBA
08/2021 - 08/2015
4LigandsIBA
03/2021 - 09/2011
4Programmed Cell Death 1 ReceptorIBA
03/2021 - 01/2020
4LipopolysaccharidesIBA
01/2021 - 01/2018
4Tyrosine Kinase InhibitorsIBA
01/2021 - 01/2014
4Gefitinib (Iressa)FDA Link
12/2020 - 09/2011
4fibrin fragment D (D-dimer)IBA
11/2020 - 07/2016
4Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2020 - 01/2014
4Carcinoembryonic AntigenIBA
01/2020 - 10/2012
4Bortezomib (Velcade)FDA Link
06/2017 - 10/2008

Therapy/Procedure

81Therapeutics
07/2022 - 01/2003
53Drug Therapy (Chemotherapy)
07/2022 - 01/2003
23Immunotherapy
10/2022 - 10/2013
17Esophagectomy
08/2021 - 01/2006
12Radiotherapy
06/2021 - 01/2003
6Neoadjuvant Therapy
11/2022 - 11/2004
6Stents
01/2017 - 01/2006
5Aftercare (After-Treatment)
01/2022 - 10/2011
5Length of Stay
01/2022 - 01/2019
4Precision Medicine
12/2021 - 01/2017
4Lasers (Laser)
05/2020 - 04/2015